Tip 2 Diyabetik Hastalarda Mobil Uygulama Kullanımının Diyabet Kontrolüne Etkisi: Bir Üniversite Hastanesi Örneği

Öz

Amaç: Bu çalışmada, geliştirilen mobil uygulamanın tip 2 diyabetik hastalarda, hastalık kontrolü üzerindeki etkisinin incelenmesi amaçlanmıştır. Gereç ve Yöntemler: Bu çalışma, ön test ve son test desenlerine sahip randomize kontrollü bir çalışmadır. Çalışmanın evrenini tip 2 diyabetik hastalar oluşturmuştur. Çalışmaya 70 katılımcı dâhil edilmiştir. Veriler, demografik veri toplama formu, diyabet tanı ve takip formu ve Türkçe Çok Boyutlu Diyabet Ölçeği kullanılarak yüz yüze görüşme yöntemiyle toplanmıştır.Normalliğin değerlendirilmesinde Kolmogorov-Smirnov testi kullanılmıştır. Veriler, tanımlayıcı istatistikler, ki-kare testleri, bağımsız örneklem t-testleri ve eşleştirilmiş örneklem t-testleri kullanılarak analiz edilmiştir. Bulgular: Katılımcıların çoğunluğunun 51 yaş ve üzeri, kadın, evli, lise mezunu, orta gelir düzeyine sahip ve çekirdek aile yapısındaki bireylerden oluştuğu bulunmuştur. Müdahale grubunda ortalama HbA1c değeri müdahale öncesi 7,71±0,9'dan müdahale sonrası 7,01±0,7'ye düşmüş olup istatistiksel olarak anlamlı bulunmuştur. Benzer şekilde, müdahale öncesi ve sonrası toplam kolesterol düzeyleri, düşük yoğunluklu lipoprotein, trigliseritler ve vücut kütle indeksi arasında istatistiksel olarak anlamlı farklılıklar bulunmuştur. Deney grubunda, hem müdahale öncesi hem de sonrası karşılaştırmalarda, Türkçe Çok Boyutlu Diyabet Ölçeği'nin tüm alt ölçekleri arasında istatistiksel olarak anlamlı bir fark bulunmuştur. Sonuç: Bu mobil uygulamanın kullanımıyla metabolik parametrelerde istatistiksel olarak anlamlı bir azalma gözlenmiştir. Bu çalışma, diyabet yönetiminin bir mobil uygulama kullanılarak iyileştirilebileceğini göstermektedir. Ancak, mobil uygulamaların diyabet kontrolü üzerindeki etkisini açıklamak için, etkinliklerinin farklı popülasyonlarda ve daha büyük örneklem büyüklükleriyle test edilmesi gerekmektedir. Bu türden mobil sağlık uygulamalarının, sağlık eşitsizliklerini ve sağlık harcamalarını azaltarak ülke refahına katkıda bulunma potansiyeli bulunmaktadır

Anahtar Kelimeler

• Diyabet
• Hastalık yönetimi
• Hastalar
• Mobil uygulamalar

The Effect of Mobile Application Use on Metabolic Control in Type 2 Diabetic Patients: The Case of a University Hospital

Öz

Aim: This study aimed to investigate the effect of the developed mobile application on disease control in patients with T2DM. Material and Methods: This study was a randomized controlled trial with pre-test and post-test designs. The study population consisted of patients with T2DM. Seventy participants were included in the study. Data were collected face-to-face using a demographic data collection form, diabetes diagnosis and follow-up form, and the Turkish Multidimensional Diabetes Scale. The normality of data was confirmed with the Kolmogorov-Smirnov test. Statistical analyses included descriptive statistics, chi-square, independent samples t-tests, and paired samples t-tests. Results: It was found that the majority of participants were individuals aged 51 and over, female, married, high school graduates, with an mean income level, and from nuclear family structures. The mean HbA1c value in the intervention group decreased from 7.71±0.9 before the intervention to 7.01±0.7 after the intervention, which was statistically significant. Similarly, statistically significant differences were found between the pre- and post-intervention total cholesterol levels, low-density lipoprotein, triglycerides, and body mass index. In the experimental group, a statistically significant difference was found among all subscales of the Turkish Multidimensional Diabetes Scale in both the pre- and post-intervention comparisons. Conclusion: The statistically significant reduction in the metabolic parameters was observed with the use of this mobile application. This study demonstrates that diabetes management can be improved using a mobile application. However, to elucidate the impact of mobile apps on diabetes control, their effectiveness should be tested in different populations and with larger sample sizes. Such mobile health applications have the potential to contribute to national welfare by reducing health inequalities and healthcare expenditures

Anahtar Kelimeler

• Diabetes mellitus
• Disease management
• Mobile applications
• Patients

Destekleyen Kurum

This work was supported by Scientific Research Program of Inonu University (No:TSA-2021-2582).

Etik Beyan

The necessary approval was obtained from the ethics committee before the commencement of the study (2021/1677). All the study stages adhered to the principles of the Declaration of Helsinki.

Teşekkür

The authors thank the patients who participated in the study.

Kaynakça

1. 1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
2. 2. Delikanlı Çorakçı B, Bilici M, Öztürk Y, Bayraktaroğlu T. The Role of Social Networks in the Monitoring and Treatment of Adolescent Diabetes. Turk J Diab Obes. 2017;1(2):49-53.
3. 3. Rhee SY, Kim C, Shin DW, Steinhubl SR. Present and future of digital health in diabetes and metabolic disease. Diabetes Metab J. 2020;44:819-27.
4. 4. Lee EY, Cha SA, Yun JS, Lim SY, Lee JH, Ahn YB, Yoon KH, Hyun MK, Ko SH. Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial. J Med Internet Res. 2022;24(7):e37430.
5. 5. Cui M, Wu X, Mao J, Wang X, Nie M. Type 2 DM self-management via smartphone applications: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(11):e0166718.
6. 6. Georgsson M, Staggers N. Patients’ perceptions and experiences of an mHealth diabetes self-management system. Comput Inform Nurs. 2017;35(3):122-30.
7. 7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28(1):54-536.
8. 8. Turkish Diabetes Foundation. Diabetes Hakkında Herşey (Internet). 2024 (Accessed Date: 25.02.2024). https://www.turkdiab. org/diyabet-hakkinda-hersey.asp?lang=TR&id=58

9. 9. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2013;36(Suppl 1):11-66.
10. 10. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017.
11. 11. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization; 2006.
12. 12. Turkish Society of Endocrinology and Metabolism. Diagnosis, treatment, and follow-up guideline for Diabetes Mellitus and its complications. 4th ed. Ankara: TEMD; 2009.
13. 13. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553-79.
14. 14. Chen YN, Su HY, Tsai ST, Lai CC, Lee CC, Chou P. ABC control of diabetes: survey data from National Diabetes Health Promotion Centers in Taiwan. Diabetes Res Clin Pract. 2009;84(2):194-200.
15. 15. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer- Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr; American Diabetes Association. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36(11):3821-42.
16. 16. Fortmann AL, Gallo LC, Garcia MI, Taleb M, Euyoque JA, Clark T, Skidmore J, Ruiz M, Dharkar-Surber S, Schultz J, Philis- Tsimikas A. Dulce Digital: An mHealth SMS-Based Intervention Improves Glycemic Control in Hispanics With Type 2 Diabetes. Diabetes Care. 2017;40(10):1349-55.
17. 17. Talbot F, Nouwen A, Gingras J, Gosselin M, Audet J. The assessment of diabetes-related cognitive and social factors: The multidimensional diabetes questionnaire. J Behav Med. 1997;20(3):291-312.
18. 18. Cosansu G, Erdogan S. Validity and reliability study of the Turkish version of the Multidimensional Diabetes Questionnaire. Anadolu Hemsirelik ve Saglik Bilimleri Dergisi. 2010;13(1):10-8.
19. 19. Hansen RC, Perrild H, Koefoed BG, Zander M. Video consultations as an add-on to standard care among patients with type 2 diabetes not responding to standard regimens: a randomized controlled trial. Eur J Endocrinol. 2017;176(6):727-36.
20. 20. Gülmez A, Kurtoğlu Y. The effect of close monitoring and counseling with a mobile device on HbA1cin individuals with type 2 diabetes. Turk Aile Hek Derg. 2024;15(1):3-14.
21. 21. Esferjani SV, Naghizadeh E, Albokordi M, Zakerkish M, Araban M. Effectiveness of a mobile-based educational intervention on self-care activities and glycemic control among the elderly with type 2 diabetes in southwest Iran in 2020. Arch Public Health. 2022;80(1):201.
22. 22. Erkoc A, Tan M. Effect of repetitive education on cognitive-social factors among type 2 diabetic patients. Int J Res Med Sci. 2017;5(6):2533-40.
23. 23. Bayraktar AK. Investigation of the effectiveness of video education delivered remotely to individuals with type 2 diabetes via mobile phones (Master’s Thesis). Balıkesir: Balıkesir Üniversitesi Sağlık Bilimleri Enstitüsü; 2019.
24. 24. Zhou W, Chen M, Yuan J, Sun Y. Welltang. A smart phonebased diabetes management application - Improves blood glucose control in Chinese people with diabetes. Diabetes Res Clin Pract. 2016;116:105-10.
25. 25. Sezgin H. Evaluation of the effect of diabetes education and telephone communication on metabolic variables in patients with type 2 diabetes (PhD Thesis). İstanbul: Marmara Üniversitesi Sağlık Bilimleri Enstitüsü; 2013.
26. 26. Sezgin H, Çınar S. Monitoring patients with type 2 diabetes via mobile phones: a randomized controlled study. Clin Exp Health Sci. 2014;3(3):173-83.
27. 27. Güner TA, Coşansu G. Disease management in individuals with type 2 diabetes using oral antidiabetic medications in primary care. Med J West Black Sea. 2022;6(2):106-14.